Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from authoritative sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Novartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion

Bloomberg

BusinessBloomberg·Jul 6, 2026·1 min read

Novartis to Buy Cancer-Drug Firm Myricx for Up to $1.5 Billion

Novartis AG agreed to buy British biotech Myricx Bio for as much as $1.5 billion, adding an experimental cancer drug designed to deliver more potent treatments directly to tumors while limiting damage to healthy cells.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Two Foreign Giants Buy Into Argentina’s Big Gas Bet

BusinessJul 6, 2026 · 1 min

Two Foreign Giants Buy Into Argentina’s Big Gas Bet

Cemex Sells Most of Its Colombia Business to Holcim

BusinessJul 6, 2026 · 1 min

Cemex Sells Most of Its Colombia Business to Holcim

Cebuana Lhuillier Money Xchange delivers better value for travelers

Philippine Daily Inquirer

BusinessJul 6, 2026 · 1 min

Cebuana Lhuillier Money Xchange delivers better value for travelers

Philippine Daily Inquirer

A French Billionaire Just Bought Telefónica’s Chile Business

BusinessJul 6, 2026 · 1 min

A French Billionaire Just Bought Telefónica’s Chile Business